- Home
- GRC vs CSTL Comparison
GRC vs CSTL Comparison
Compare GRC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRC
- CSTL
- Stock Information
- Founded
- GRC 1933
- CSTL 2007
- Country
- GRC United States
- CSTL United States
- Employees
- GRC N/A
- CSTL N/A
- Industry
- GRC Fluid Controls
- CSTL Medical Specialities
- Sector
- GRC Industrials
- CSTL Health Care
- Exchange
- GRC Nasdaq
- CSTL Nasdaq
- Market Cap
- GRC 1.0B
- CSTL 848.1M
- IPO Year
- GRC N/A
- CSTL 2019
- Fundamental
- Price
- GRC $37.60
- CSTL $24.94
- Analyst Decision
- GRC
- CSTL Strong Buy
- Analyst Count
- GRC 0
- CSTL 6
- Target Price
- GRC N/A
- CSTL $40.33
- AVG Volume (30 Days)
- GRC 64.9K
- CSTL 434.0K
- Earning Date
- GRC 02-07-2025
- CSTL 02-26-2025
- Dividend Yield
- GRC 1.97%
- CSTL N/A
- EPS Growth
- GRC 33.88
- CSTL N/A
- EPS
- GRC 1.45
- CSTL 0.21
- Revenue
- GRC $657,528,000.00
- CSTL $311,878,000.00
- Revenue This Year
- GRC $1.05
- CSTL $51.29
- Revenue Next Year
- GRC $3.60
- CSTL N/A
- P/E Ratio
- GRC $25.88
- CSTL $118.55
- Revenue Growth
- GRC 1.95
- CSTL 62.43
- 52 Week Low
- GRC $30.47
- CSTL $16.97
- 52 Week High
- GRC $43.79
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- GRC 43.39
- CSTL 36.58
- Support Level
- GRC $35.48
- CSTL $23.95
- Resistance Level
- GRC $37.97
- CSTL $26.52
- Average True Range (ATR)
- GRC 0.81
- CSTL 2.08
- MACD
- GRC 0.09
- CSTL -0.36
- Stochastic Oscillator
- GRC 66.30
- CSTL 11.26
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.